Ausgabe 5/2024
Inhalt (6 Artikel)
Measuring Quality of Life in Deprescribing Trials: A Scoping Review
Wade Thompson, Carina Lundby, Adam Bleik, Harman Waring, Jung Ah Hong, Chris Xi, Carmel Hughes, Douglas M. Salzwedel, Emily G. McDonald, Jennifer Pruskowski, Sion Scott, Anne Spinewine, Jean S. Kutner, Trine Graabæk, Shahrzad Elmi, Frank Moriarty
Rho Kinase Inhibitors: Strategies in Glaucoma Treatment in Older Adults
Emily Schehlein, Alan Robin
Association of Tumor Necrosis Factor-α Inhibitors with Incident Dementia: Analysis Based on Population-Based Cohort Studies
Saskia Berger, Kristine F. Moseholm, Emilie R. Hegelund, Falko Tesch, Minh Chau S. Nguyen, Laust H. Mortensen, Majken K. Jensen, Jochen Schmitt, Kenneth J. Mukamal
Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study
Estelle Tran Van Hoi, Stella Trompet, Yara Van Holstein, Frederiek Van Den Bos, Diana Van Heemst, Henrik Codrington, Geert Labots, Suzanne Lohman, Asli Ozkan, Johanneke Portielje, Simon P. Mooijaart, Nienke A. De Glas, Marloes Derks
Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia
Rizwan Qaisar, Imran M. Khan, Asima Karim, Tahir Muhammad, Firdos Ahmad